Three months post-treatment, imaging revealed tumor regression (from 100 mm to 60 mm) and significant decline in tumor markers (AFP 1550–110 ng/mL; PIVKA-2 32,600 to 79 AU/mL). Here, AFP is linked to neoplasm.